| abstract |
Provided are an antibody against hepatitis B surface antigen, an encoding nucleic acid and a preparation method thereof, and a pharmaceutical composition comprising the antibody. Also provided are uses of the antibody and the pharmaceutical composition. The antibody and the pharmaceutical composition can be used to prevent and/or treat HBV infection or a disease related to HBV infection (e.g., hepatitis B), neutralize virulence of HBV in the body of a subject (e.g., human), and decrease serum levels of HBV DNA and/or HBsAg. |